Taiwan’s medical and biotech industries are expanding rapidly, driving strong demand for talent and dynamic market changes. The talent needs in Taiwan’s biotech and pharmaceutical industry are concentrated in several core functional areas, including Commercial (sales & marketing), Medical Affairs, Market Access, Clinical Operations, Regulatory Affairs, as well as clinical development roles like Biostatistics and Data Management.

In digital health, Taiwan can leverage its strong ICT industry to integrate tech with healthcare (for example, developing smart hospitals and health management platforms), and talent development in this area can benefit from the country’s solid IT talent base. However, there is still a dearth of professionals adept in both healthcare and technology, calling for enhanced biomedical informatics programs and industry-academic collaboration. In precision medicine, Taiwan has a favorable clinical trial environment and rich biobank resources to invest in cancer genomics and targeted therapy studies, but it urgently needs specialists in bioinformatics, clinical genetics, and related areas. In the rare diseases field, Taiwan has introduced regulatory incentives for orphan drugs, encouraging companies to develop and bring in treatments for rare conditions. Consequently, demand will grow for talent well-versed in global orphan drug regulations and clinical trial design for small patient populations.

More: https://invest.taipei/en/taiwan-medical-biotech-talent-market-report-2/